Validation Has a New Glo

The ViraGlo's noninfectious Fluorescent Viral Surrogates™ enable rapid quantification of filtration and purification performance, accelerating validation testing and process development.

The Power of our Fluorescent Viral Surrogate™ Platform

ViraGlo™️ viral surrogates are engineered to mimic the physicochemical properties of live pathogens in a Biosafety Level 1 (BSL-1) environment.

Safe

Non-Pathogenic Solution to Live Virus

Learn More

Cost-Effective

Streamlined Workflow for User

Learn More

Reliable

Highly Resolved Quantification

Learn More

How We Compare

First to Meet Accuracy & Precision on Live Virus Quantification

Live Virus Spiking

Live Infectious Viruses

4-7 Months of Study Time

Labor Intensive, Complex, Error-Prone Quantification

High Operational Costs

Logo

Noninfectious Functionalized Nanoparticles

1-3 Months of Study Time*

Simple & Direct Fluorescence-Based Quantification

Reduces Operational Costs by 83%

*Inclusive of all pre-study preparation and post-study data analysis and reporting.

*Inclusive of all pre-study preparation and post-study data analysis and reporting.

Browse Our Products

Designed for Critical Validation Challenges In:

Designed for Critical Validation Challenges In:

Viral Clearance Validation

Directly measure the log reduction value (LRV) of downstream purification processes using our easily quantifiable Fluorescent  Viral Surrogates™.

Directly measure the log reduction value (LRV) of downstream purification processes using our easily quantifiable Fluorescent Viral Surrogates™.

Anti-Viral/Microbial Surface Validation

Rapidly assess the performance of antimicrobial surfaces.

Virus-Host Interaction Research

Safely investigate viral attachment, entry, and cellular interactions.

HVAC

Quantify airborne particle capture in air purification systems

Water Treatment

Validate viral removal efficacy in water purification systems.

Cross-section of non-enveloped and enveloped Fluorescent Viral Surrogates.™

Cross-section of non-enveloped and enveloped Fluorescent Viral Surrogates.™

Say hello to

Say hello to

  • Noninfectious Alternatives

  • Rapid Quantification

  • Reduced Study Timelines

  • Lower Operational Costs

  • Streamlined Procedures  

  • In-House Validation

  • Expedited Product Launches

  • Noninfectious Alternatives

  • Rapid Quantification

  • Reduced Study Timelines

  • Lower Operational Costs

  • Streamlined Procedures  

  • In-House Validation

  • Expedited Product Launches

We’d Love to Hear
From You

Reach out for quotes, support, or feedback.

Contact Us